Cibus, Inc.

Listed Company

CBUSCIK 0001705843NasdaqNon-AcceleratedSmaller ReportingAgricultural ChemicalsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$3.64M

Net Income

$-127.08M

Total Assets

$305.05M

Equity

$21.83M

Shares Out

54.26M

Op. Cash Flow

$-50.60M

Business

Cibus, Inc. is an agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits. It offers the RTDS/ Trait Machine gene‑editing platform services and develops productivity traits such as herbicide tolerance, pod shatter reduction, and disease resistance, as well as partner‑funded sustainable ingredient projects. Key business segments include crop‑specific platforms and trait development for Canola, Rice, Wheat, and Soybean and collaborations for AI and ingredient development. It targets seed company customers globally via material transfer collaborations and licensing across the Americas, Europe, and Asia.

Summary from filing dated 2025-03-20

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Total revenue	4	4	2	157,000	26
Research and development	44	50	42	12	11
Selling, general, and administrative	27	31	29	11	—
Goodwill impairment	21	181	—	—	—
Long-lived assets impairment	9	0	—	—	—
Total operating expenses	101	263	321	23	27
Loss from operations	−98	−258	−319	−22	−29
Royalty liability interest expense - related parties	−35	−34	−19	0	—
Other interest income, net	438,000	631,000	527,000	−87,000	−1
Non-operating income, net	400,000	9	−395,000	6	—
Loss before income taxes	−132	−283	−338	−17	−29
Income tax expense	−29,000	−29,000	4,000	0	0
Net loss	−132	−283	−338	−17	—
Net loss attributable to noncontrolling interest and redeemable noncontrolling interest	−5	−31	—	—	—
Net loss attributable to Cibus, Inc. stockholders	−127	−251	−268	−17	−29
Basic net loss per share of Class A common stock (in dollars per share)	−2.78	−10.83	−25.95	−18.36	−0.78
Diluted net loss per share of Class A common stock (in dollars per share)	−2.78	−10.83	−25.95	−18.36	−0.78
Weighted average shares of Class A common stock outstanding - basic (in shares)	46	23	10	919,959	37
Weighted average shares of Class A common stock outstanding - diluted (in shares)	46	23	10	919,959	37

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2023 2023-05-31	FY 2022 2022-12-31
Cash and cash equivalents	10	14	33	—	3
Accounts receivable	503,000	1	500,000	—	0
Prepaid expenses and other current assets	2	1	2	—	606,000
Total current assets	12	17	35	—	4
Property, plant, and equipment, net	6	11	16	—	5
Operating lease right-of-use assets	22	33	22	—	14
Intangible assets, net	32	34	35	—	0
Goodwill	233	253	435	585	0
Other non-current assets	926,000	1	1	—	0
Total assets	305	350	544	—	22
Accounts payable	8	6	6	—	340,000
Accrued expenses	2	2	2	—	173,000
Accrued compensation	3	3	4	—	107,000
Deferred revenue	500,000	932,000	1	—	107,000
Current portion of notes payable	435,000	436,000	833,000	—	0
Current portion of financing lease obligations	0	113,000	187,000	—	97,000
Current portion of operating lease obligations	3	4	6	—	367,000
Class A common stock warrants	79,000	2	1	—	291,000
Other current liabilities	0	288,000	16,000	—	479,000
Total current liabilities	17	20	21	—	2
Notes payable, net of current portion	93,000	226,000	536,000	—	0
Operating lease obligations, net of current portion	30	31	17	—	13
Royalty liability - related parties	235	199	165	—	0
Other non-current liabilities	2	1	2	—	79,000
Total liabilities	283	252	206	—	15
Commitments and contingencies (See Note 9)	—	—	—	—	—
Redeemable noncontrolling interest	0	6	45	—	0
Additional paid-in capital	882	825	775	—	220
Class A common stock in treasury, at cost; 193,195 shares as of December 31, 2025, and 45,177 shares as of December 31, 2024	−2	−2	−2	—	−1
Accumulated deficit	−858	−731	−480	—	−212
Accumulated other comprehensive income	39,000	15,000	8,000	—	0
Total stockholders equity	22	92	293	—	7
Total liabilities, redeemable noncontrolling interest, and stockholders equity	305	350	544	—	22

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	6	7	5	2	2
Stock-based compensation	8	11	16	4	2
Loss on disposal of assets, net	41,000	335,000	—	—	—
Change in fair value of liability classified Class A common stock warrants	−447,000	−9	1	−5	—
Other	38,000	22,000	21,000	0	—
Accounts receivable	538,000	−512,000	2	0	5
Prepaid expenses and other current assets	983,000	518,000	1	389,000	3
Accounts payable	720,000	−188,000	2,000	−229,000	−360,000
Accrued expenses	−367,000	608,000	−2	−166,000	—
Accrued compensation	−268,000	−535,000	891,000	−2	572,000
Deferred revenue	−403,000	−285,000	−89,000	−56,000	—
Right-of-use assets and lease obligations, net	1	990,000	−106,000	199,000	—
Other assets and liabilities, net	−28,000	−213,000	−431,000	−610,000	—
Net cash used in operating activities	−51	−58	−46	−19	−19
Purchases of property, plant, and equipment	−578,000	−808,000	−4	−2	−497,000
Net cash used in investing activities	−578,000	−808,000	55	−2	11
Proceeds from issuances of securities	50	44	20	—	—
Costs incurred related to issuances of securities	−2	−2	−2	—	—
Payment of taxes related to restricted stock units withheld from employees	−142,000	−214,000	−742,000	0	0
Proceeds from issuance of notes payable	0	204,000	1	0	—
Repayments of financing lease obligations	−113,000	−171,000	—	—	—
Repayments of notes payable	−995,000	−912,000	−1	0	—
Net cash provided by financing activities	47	41	20	10	4
Effect of exchange rate changes on cash and cash equivalents	11,000	−13,000	3,000	0	—
Net decrease in cash and cash equivalents	−5	−18	29	−11	−4

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro